研究
教育
解決策
サインイン
JA
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Oncology R&D group
Jonathon Golas has not added Biography.
If you are Jonathon Golas and would like to personalize this page please email our Author Liaison for assistance.
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
Oncotarget Feb, 2015 | Pubmed ID: 25671303
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
Proceedings of the National Academy of Sciences of the United States of America 12, 2018 | Pubmed ID: 30487219
Pfizer Worldwide Research and Development
Shuang Chen1,
Andreas Giannakou1,
Jonathon Golas1,
Kenneth G. Geles1
1Oncology R&D group, Pfizer Worldwide Research and Development
個人情報保護方針
利用規約
一般データ保護規則
お問い合わせ
図書館への推薦
JoVE ニュースレター
JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
著者
図書館員
アクセス
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved
